Skip to main content

Advertisement

Log in

B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation

  • PRECLINICAL STUDIES
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

In the course of screening for novel anticancer compounds, B1 (N-(2-(Dimethylamino)ethyl)-2-aminothiazonaphthalimide), a novel naphthalimide-based DNA intercalator, was generated as a new anticancer candidate. For the first time, our investigation demonstrates that B1 inhibited the growth of HeLa cells by the induction of cell cycle arrest and apoptosis. Analysis of flow cytometry and western blots of HeLa cells treated with B1 revealed an appreciable cell cycle arrest and apoptotic induction in dose and time-dependent manner via the p53-dependent pathway. Furthermore, the release of cytochrome c from mitochondria was detected using confocal microscopy in HeLa cells treated with B1. Accordingly, these data demonstrate that the anticancer activity of B1 is associated with the activation of p53 and the release of cytochrome c, which suggest that B1 might have therapeutic potential against cervix carcinoma as an effective lead compound.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

Abbreviations

B1:

N-(2-(Dimethylamino)ethyl)-2-aminothiazonaphthalimide

DMSO:

Dimethyl sulfoxide

MTT:

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

PI:

Propidium iodide

BCIP:

5-bromo-4-chloro-3-indolyl-phosphate

NBT:

Nitro blue tet-razolium

PMSF:

Phenylmethylsulfonyl fluoride

References

  1. Viglasky V, Danko P (2007) Intercalators: contra cruciform extrusion in DNA. Anal Biochem 360:7–13

    Article  PubMed  CAS  Google Scholar 

  2. Berman HM, Young PR (1981) The interaction of intercalating drugs with nucleic acids. Annu Rev Biophys Bioeng 10:87–114

    Article  PubMed  CAS  Google Scholar 

  3. Wilson WD, Jones RL (1981) Intercalating drugs: DNA binding and molecular pharmacology. Adv Pharmacol Chemother 18:177–222

    Article  PubMed  CAS  Google Scholar 

  4. Martinez R, Chacon-Garcia L (2005) The search of DNA intercalators as antitumoral drugs: what it worked and what did not work. Curr Med Chem 12:127–151

    PubMed  CAS  Google Scholar 

  5. Qian XH, Li ZG, Yang Q (2007) Highly efficient antitumor agents of heterocycles containing sulfur atom: Linear and angular thiazonaphthalimides against human lung cancer cell in vitro. Bioorgan Med Chem 15:6846–6851

    Article  CAS  Google Scholar 

  6. Benchimol S (2001) P53-dependent pathways of apoptosis. Cell Death Differ 8:1049–1051

    Article  PubMed  CAS  Google Scholar 

  7. Park HY, Kim MK, Moon SI et al (2006) Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53/p21WAF1/CIP1 pathway. Cancer Sci 97:430–436

    Article  PubMed  CAS  Google Scholar 

  8. Colman MS, Afshari CA, Barrett JC (2000) Regulation of p53 stability and activity in response to genotoxic stress. Mutat Res 462:179–188

    Article  PubMed  CAS  Google Scholar 

  9. Liu LJ, Yang F, Zhang Y, Li JL (2007) Studies on the cell immunosuppressive mechanism of Oridonin from Isodon serra. Int Immunopharm 7:945–954

    Article  CAS  Google Scholar 

  10. Wang G, Chen HF, Huang MH et al (2006) Methyl protodioscin induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells. Cancer Lett 241:102–109

    Article  PubMed  CAS  Google Scholar 

  11. Verma M, Singh SK, Bhushan S et al (2008) In vitro cytotoxic potential of Polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrial-dependent pathway in HL-60 cells. Chem-Biol Interact 171:45–56

    Article  PubMed  CAS  Google Scholar 

  12. Levites Y, Youdim MBH, Maor G, Mandel S (2002) Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclearfactor-kappa B (NF-kappa B) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63:21–29

    Article  PubMed  CAS  Google Scholar 

  13. Zhang J, Shen YL, Liu JW, Wei DZ (2005) Antimetastatic effect of prodigiosin through inhibition of tumor invasion. Biochem Pharmacol 69:407–414

    Article  PubMed  CAS  Google Scholar 

  14. Liu Y, Zhang SP, Cai YQ (2007) Cytoprotective effects of selenium on cadmium-induced LLC-PK1 cells apoptosis by activating JNK pathway. Toxicol In Vitro 21:677–684

    Article  PubMed  CAS  Google Scholar 

  15. Dedov VN, Dedova IV, Nicholson GA (2003) Inhibition of topoisomerase II overrides the G2/M checkpoints of the cell cycle in EBV-lymphocytes. Apoptosis 8:399–406

    Article  PubMed  CAS  Google Scholar 

  16. Li CL, Wu HZ, Xu W et al (2008) 6-O-Angeloylenolin induces apoptosis through a mitochondrial/caspase and NF-κB pathway in human leukemia HL60 cell. Biomed Pharmacother 62:401–409

    Article  CAS  Google Scholar 

  17. Rello S, Stockert JC, Moreno V et al (2005) Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 10:201–208

    Article  PubMed  CAS  Google Scholar 

  18. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C (2000) The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 14:289–300

    PubMed  CAS  Google Scholar 

  19. Andreassen PR, Lacroix FB, Lohez OD, Margolis RL (2001) Neither p21WAF1 nor 14-3-3 sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells. Cancer Res 61:7660–7668

    PubMed  CAS  Google Scholar 

  20. Haupt S, Berger M, Goldberg Z, Haupt Y (2003) Apoptosis—the p53 network. J Cell Sci 116:4077–4085

    Article  PubMed  CAS  Google Scholar 

  21. Innocente SA, Abrahamson JLA, Cogswell JP, Lee JM (1999) p53 regulates a G2 checkpoint through Cyclin B1. Proc Natl Acad Sci USA 96:2147–2152

    Article  PubMed  CAS  Google Scholar 

  22. Sherr CJ (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60:3689–3695

    PubMed  CAS  Google Scholar 

  23. Mousli M, Hopfner R, Abbady AQ et al (2003) ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Brit J Cancer 89:120–127

    Article  PubMed  CAS  Google Scholar 

  24. Arima Y, Hirota T, Bronner C et al (2004) Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells 9:131–142

    Article  PubMed  CAS  Google Scholar 

  25. Hu W, Kavanagh JJ (2003) Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 4:721–729

    Article  PubMed  CAS  Google Scholar 

  26. Andrew M (1995) Cyclin ubiquitination: the destructive end of mitosis. Cell 81:149–152

    Article  Google Scholar 

  27. Antonsson B, Martinou JC (2000) The Bcl-2 protein family. Exp Cell Res 256:50–57

    Article  PubMed  CAS  Google Scholar 

  28. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387:773–776

    Article  PubMed  CAS  Google Scholar 

  29. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326:1–16

    PubMed  CAS  Google Scholar 

  30. Ashkenazi A, Dixit VM (1998) Death receptor: signaling and modulation. Science 281:1305–1308

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Shanghai Leading Academic Discipline Project, Project No. B507, the National Special Fund for State Key Laboratory of Bioreactor Engineering, Grant No. 2060204 and the 111 Project, Grant No. B07023.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jianwen Liu or Xuhong Qian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liang, X., Wu, A., Xu, Y. et al. B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation. Invest New Drugs 29, 646–658 (2011). https://doi.org/10.1007/s10637-010-9403-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-010-9403-9

Keywords

Navigation